Search Results

There are 4585 results for: content related to: Inhibitory Effects of Silibinin on Cytochrome P-450 Enzymes in Human Liver Microsomes

  1. You have free access to this content
    Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 1262–1271, Stephen J. Polyak, Peter Ferenci and Jean-Michel Pawlotsky

    Version of Record online : 28 FEB 2013, DOI: 10.1002/hep.26179

  2. You have full text access to this Open Access content
    Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease

    Journal of Veterinary Internal Medicine

    Volume 27, Issue 1, January/February 2013, Pages: 10–16, E.S. Hackett, D.C. Twedt and D.L. Gustafson

    Version of Record online : 9 NOV 2012, DOI: 10.1111/jvim.12002

  3. Milk thistle in liver diseases: past, present, future

    Phytotherapy Research

    Volume 24, Issue 10, October 2010, Pages: 1423–1432, Ludovico Abenavoli, Raffaele Capasso, Natasa Milic and Francesco Capasso

    Version of Record online : 7 JUN 2010, DOI: 10.1002/ptr.3207

  4. You have free access to this content
    Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: Comparison with silymarin and silibinin

    International Journal of Cancer

    Volume 123, Issue 12, 15 December 2008, Pages: 2750–2758, Gagan Deep, Komal Raina, Rana P. Singh, Nicholas H. Oberlies, David J. Kroll and Rajesh Agarwal

    Version of Record online : 16 SEP 2008, DOI: 10.1002/ijc.23879

  5. You have free access to this content
    Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking

    Cellular Microbiology

    Volume 15, Issue 11, November 2013, Pages: 1866–1882, Julie Blaising, Pierre L. Lévy, Claire Gondeau, Capucine Phelip, Mihayl Varbanov, Elodie Teissier, Florence Ruggiero, Stephen J. Polyak, Nicholas H. Oberlies, Tijana Ivanovic, Steeve Boulant and Eve-Isabelle Pécheur

    Version of Record online : 13 JUN 2013, DOI: 10.1111/cmi.12155

  6. Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells

    Molecular Carcinogenesis

    Volume 30, Issue 4, 2001, Pages: 224–236, Yogesh Sharma, Chapla Agarwal, Ashvani K. Singh and Rajesh Agarwal

    Version of Record online : 30 APR 2001, DOI: 10.1002/mc.1032

  7. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization

    Journal of Neuroscience Research

    Volume 93, Issue 5, May 2015, Pages: 755–765, Yujeong Lee, Hee Ra Park, Hye Jeong Chun and Jaewon Lee

    Version of Record online : 9 FEB 2015, DOI: 10.1002/jnr.23544

  8. You have free access to this content
    Multiple effects of silymarin on the hepatitis C virus lifecycle

    Hepatology

    Volume 51, Issue 6, June 2010, Pages: 1912–1921, Jessica Wagoner, Amina Negash, Olivia J. Kane, Laura E. Martinez, Yaakov Nahmias, Nigel Bourne, David M. Owen, Joe Grove, Claire Brimacombe, Jane A. McKeating, Eve-Isabelle Pécheur, Tyler N. Graf, Nicholas H. Oberlies, Volker Lohmann, Feng Cao, John E. Tavis and Stephen J. Polyak

    Version of Record online : 12 FEB 2010, DOI: 10.1002/hep.23587

  9. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells

    The Prostate

    Volume 53, Issue 3, 1 November 2002, Pages: 211–217, Alpana Tyagi, Neehar Bhatia, Mark S. Condon, Maarten C. Bosland, Chapla Agarwal and Rajesh Agarwal

    Version of Record online : 17 OCT 2002, DOI: 10.1002/pros.10146

  10. You have free access to this content
    Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells

    International Journal of Cancer

    Volume 123, Issue 1, 1 July 2008, Pages: 41–50, Gagan Deep, Nicholas H. Oberlies, David J. Kroll and Rajesh Agarwal

    Version of Record online : 8 APR 2008, DOI: 10.1002/ijc.23485

  11. Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line

    Cell Biology International

    Volume 32, Issue 8, August 2008, Pages: 888–892, Mohammad Javad Mokhtari, Nasrin Motamed and Mohammad Ali Shokrgozar

    Version of Record online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2008.03.019

  12. Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum

    Phytotherapy Research

    Volume 17, Issue 5, May 2003, Pages: 524–530, Zdeněk Švagera, Nina Škottová, Petr Váňa, Rostislav Večeřa, Karel Urbánek, Marie Belejová, Pavel Kosina and Vilím Šimánek

    Version of Record online : 1 MAY 2003, DOI: 10.1002/ptr.1187

  13. Silymarin inhibits melanoma cell growth both in vitro and in vivo by targeting cell cycle regulators, angiogenic biomarkers and induction of apoptosis

    Molecular Carcinogenesis

    Volume 54, Issue 11, November 2015, Pages: 1328–1339, Mudit Vaid, Tripti Singh, Ram Prasad and Santosh K. Katiyar

    Version of Record online : 30 AUG 2014, DOI: 10.1002/mc.22208

  14. Assessing the Clinical Significance of Botanical Supplementation on Human Cytochrome P450 3A Activity: Comparison of a Milk Thistle and Black Cohosh Product to Rifampin and Clarithromycin

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 201–213, Dr Bill Gurley, Ms Martha A. Hubbard, Dr D. Keith Williams, Dr John Thaden, Mr Yudong Tong, Dr W. Brooks Gentry, Dr Philip Breen, Dr Danielle J. Carrier and Dr Shreekar Cheboyina

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005284854

  15. Prostate cancer chemoprevention by silibinin: Bench to bedside

    Molecular Carcinogenesis

    Volume 45, Issue 6, June 2006, Pages: 436–442, Rana P. Singh and Rajesh Agarwal

    Version of Record online : 24 APR 2006, DOI: 10.1002/mc.20223

  16. You have full text access to this Open Access content
    Chemopreventive Effects of a Flavonoid Antioxidant Silymarin on N-Butyl-N-(4- hydroxybutyl)nitrosamine-induced Urinary Bladder Carcinogenesis in Male ICR Mice

    Japanese Journal of Cancer Research

    Volume 93, Issue 1, January 2002, Pages: 42–49, Pham Quang Vinh, Shigeyuki Sugie, Takuji Tanaka, Akira Hara, Yasuhiro Yamada, Masaki Katayama, Takashi Deguchi and Hideki Mori

    Version of Record online : 22 AUG 2005, DOI: 10.1111/j.1349-7006.2002.tb01199.x

  17. Silymarin Inhibits Cervical Cancer Cell Through an Increase of Phosphatase and Tensin Homolog

    Phytotherapy Research

    Volume 26, Issue 5, May 2012, Pages: 709–715, Hann-Chin Yu, Li-Jen Chen, Kai-Chun Cheng, Ying-Xiao Li, Ching-Hua Yeh and Juei-Tang Cheng

    Version of Record online : 20 OCT 2011, DOI: 10.1002/ptr.3618

  18. Milk Thistle [Silybum marianum (L.) Gaertner]

    Medical Toxicology of Natural Substances: Foods, Fungi, Medicinal Herbs, Plants, and Venomous Animals

    Donald G. Barceloux, Pages: 553–557, 2008

    Published Online : 2 JAN 2008, DOI: 10.1002/9780470330319.ch80

  19. Biological analysis of herbal medicines used for the treatment of liver diseases

    Biomedical Chromatography

    Volume 25, Issue 1-2, January - February 2011, Pages: 21–38, Chao-Feng Chien, Yu-Tse Wu and Tung-Hu Tsai

    Version of Record online : 28 DEC 2010, DOI: 10.1002/bmc.1568

  20. You have free access to this content
    Silymarin Inhibits Cell Cycle Progression and mTOR Activity in Activated Human T Cells: Therapeutic Implications for Autoimmune Diseases

    Basic & Clinical Pharmacology & Toxicology

    Volume 112, Issue 4, April 2013, Pages: 251–256, Marjan Gharagozloo, Elahe N. Javid, Abbas Rezaei and Kazem Mousavizadeh

    Version of Record online : 24 DEC 2012, DOI: 10.1111/bcpt.12032